Congratulations to Lauren Houghton, Chin Hur, Markus D. Siegelin, and Neil Vasan, the new Class of Velocity Fellows, for their innovative, life-changing cancer research.
New awards program supports cutting-edge research dedicated to the study and treatment of MDS, a malignant disease that attacks bone marrow stem cells.
With a new three-year, $775,000 Translational Research Program grant by The Leukemia & Lymphoma Society, Dr. Lentzsch and collaborators unveil a promising new approach to treat multiple myeloma.
Study findings not only show that these mutations can contribute to diffuse large B cell lymphoma, but they identify an approach that should be useful for the analysis of other types of tumors.
Which patients respond less well to radiation therapy and why? Find out how the Spina lab is approaching this problem from the perspective of the immune system.
Columbia Cancer congratulates Drs. Catherine Spina and Aaron Viny, recipients of a prestigious Clinical Scientist Development Award by the Doris Duke Charitable Foundation.
Angela Christiano's groundbreaking research in alopecia areata led to the first FDA-approved systemic treatment for the autoimmune disease, and could also point the way to new cancer therapies.
